July. 16, 2013 |
|
Dec. 17, 2018 |
|
jRCT2080222144 |
Exploratory clinical trial of KIB-PCI in healthy Japanese children |
|
version: date: |
DAIICHISANKYO Co.,Ltd. |
||
http://www.daiichisankyo.co.jp/contact/clinical/index.html |
||
30 | ||
Interventional |
||
Single-center, uncontrolled, open-label study |
||
2 |
||
1) healthy Japanese children |
||
1) Subjects with history of H5N1 influenza |
||
No limit | ||
No limit | ||
Both |
||
Prophylaxis of new type of influenza infection |
||
investigational material(s) |
||
SRH antibody titer |
||
HI antibody titer |
DAIICHISANKYO Co.,Ltd. | |
KITASATO DAIICHI SANKYO VACCINE COMPANY, LIMITED |
JapicCTI-132190 | |